Form 4: DocuSign Director Michael Rosenbaum Exercises RSUs

Director Michael Rosenbaum acquired 522 shares of DocuSign common stock through the vesting of restricted stock units.

Summary

• Director Michael Rosenbaum exercised 522 restricted stock units (RSUs) on June 3, 2026.
• The RSUs converted into 522 shares of DocuSign common stock at a price of $0 per share.
• Following the transaction, the director's total beneficial ownership of common stock increased to 1,566 shares.
• The remaining balance of unvested RSUs held by the director is 4,699.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event reflecting standard compensation practices rather than a change in company outlook.

Positives

• Director maintains a direct equity stake in the company, aligning interests with shareholders.

Negatives

• None identified; this is a routine equity compensation event.

Risks

• None identified; this is a standard administrative filing regarding equity compensation.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a disclosure of director equity transactions.

Industry Context

StockSavvy.ai notes that routine RSU vesting for board members is a standard component of executive and director compensation packages in the SaaS industry, signaling no change in strategic direction.

Comparison to Industry Standards

• The transaction follows standard equity compensation practices for publicly traded technology companies.
• The vesting schedule of three years is consistent with typical retention structures for board members at companies like Adobe or Salesforce.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity compensation event.

Next Steps

• Continued vesting of remaining 4,699 RSUs in quarterly installments.

Key Dates

Keywords

DocuSign, DOCU, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units